<--GAT-->

Cleveland VA Pharmacy Clinic Shows Promise in Heart Failure Pilot

by U.S. Medicine

August 28, 2017

CLEVELAND – A pilot evaluation of a pharmacist-led, multidisciplinary transitional care clinic for heart failure (HF) patients showed good results at the Louis Stokes Cleveland VAMC in Cleveland.

The report, published in Progress in Cardiovascular Diseases, noted that transitions of care in HF should include:

  • medication reconciliation,
  • multidisciplinary care,
  • early post-discharge follow-up, and
  • prompt intervention on HF signs and symptoms.

The VA pharmacy authors hypothesized that combining the elements with optimization of medications would positively affect outcomes.1

The SERIOUS HF Medication Reconciliation Transitional Care Clinic (HF MRTCC) was used to test that. Patients were seen by a heart-failure trained clinical pharmacist, who performed medication reconciliation, a basic physical exam, and a HF symptom history. All of the 135 patients had a diagnosis of HF, with 59% having been recently discharged from the hospital.

During the pilot, medications were adjusted by the clinical pharmacist or medical provider. Data were retrospectively collected for a quality improvement evaluation of this novel clinic on medication discrepancies, medications optimized, and 30-day readmissions…

Results indicated that the mean time from discharge to the clinic appointment was 10+6 days, and the 30-day all-cause readmission rate was 9%. Study authors reported that medication discrepancies were detected in 53% of patients.

Medications were optimized in 70% of patients, usually involving beta blockers, ace inhibitors, and diuretics. In patients with an ejection fraction of 40% or below, significantly higher doses of beta blockers and ace inhibitors generally were prescribed after the clinic visit, they said.

“The HF MRTCC identified and corrected numerous medication discrepancies, up-titrated medications, and was associated with a 30-day readmission rate of 9%,” the researchers concluded. “These encouraging pilot results are hypothesis-generating and warrant further controlled trials.”

  1. Milfred-LaForest SK, Gee JA, Pugacz AM, Piña IL, Hoover DM, Wenzell RC, Felton A, Guttenberg E, Ortiz J. Heart failure transitions of care: A pharmacist-led post- discharge pilot experience. Prog Cardiovasc Dis. 2017 Aug 18. pii:S0033-0620(17)30113-5. doi: 10.1016/j.pcad.2017.08.005. [Epub ahead of print] Review. PubMed PMID: 28826670.

Comments are closed here.


Related Articles

NASA Partners with Academia for CVD Prediction Tool in Younger Adults

Federal medicine played a crucial role in the development of a new online tool to better predict which middle-aged adults are at the greatest risk of having acute myocardial infarction or stroke over the next decade.

VA Research Determines Which Beta Blocker Is Better in Heart Failure

ST. LOUIS—Current clinical guidelines recommend the use of beta blockers in all heart failure patients with with reduced ejection fraction (HFrEF). Which beta blocker to use—carvedilol or metoprolol succinate—remained unclear, however, according to a recent... View Article


U.S. Medicine Recommends


More From cardiology

Cardiology

NASA Partners with Academia for CVD Prediction Tool in Younger Adults

Federal medicine played a crucial role in the development of a new online tool to better predict which middle-aged adults are at the greatest risk of having acute myocardial infarction or stroke over the next decade.

Cardiology

VA Research Determines Which Beta Blocker Is Better in Heart Failure

WASHINGTON—Recent problems with initiatives implemented by the Veterans Benefits Administration point to much larger, systemic issues in how the agency rolls out new programs, according to the VA Office of the Inspector General. Appearing before... View Article

Cardiology

New VA Analysis Refutes Link Between Heart Failure, Incident Cancer

With about 350,000 patients with heart failure diagnoses being treated in the VHA, recent studies suggesting that the cardiovascular condition increases risk of cancer have been worrisome.

Cardiology

Medications, interventions underused in veterans with peripheral artery disease

Nearly 30% of veterans with peripheral artery disease (PAD) die within four years of diagnosis, while others experience limb amputation or critical limb ischemia.

Cardiology

Rank as socioeconomic proxy affects stroke outcomes in MHS patients

Do socioeconomic disparities exist in the U.S. military healthcare system with ischemic stroke admissions? A new study says they do.

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up